Table 3.
Subject characteristics
| Group A (Active treatment group) | Group B (Sham-controlled group) | Statistics | P value | |
|---|---|---|---|---|
| Age (years) | 36.112 ± 11.495 | 38.083 ± 12.106 | T = 1.047 | 0.297 |
| Gendera (males/female) | 29/35 | 36/28 | x 2=1.532 | 0.216 |
| Weight (kg) | 60.391 ± 9.407 | 59.817 ± 8.697 | t = 0.177 | 0.860 |
| Height (cm)b | 166.031 ± 6.575 | 164.752 ± 6.731 | U = 1854.5 | 0.356 |
| Pulse (beats/min)b | 75.828 ± 6.870 | 77.297 ± 6.004 | U = 1788.000 | 0.214 |
| EO (109/L)b | 0.201 ± 0.132 | 0.195 ± 0.139 | U = 1952.000 | 0.647 |
| AST (U/L) | 28.141 ± 7.322 | 29.672 ± 9.952 | t = −0.991 | 0.324 |
| ALT (U/L) | 21.656 ± 6.393 | 23.125 ± 6.646 | t = −1.274 | 0.205 |
| BUN (mmol/L)b | 4.572 ± 1.540 | 4.988 ± 1.325 | U = 1804.000 | 0.245 |
| Crea (μmol/L)b | 53.367 ± 11.068 | 56.094 ± 9.018 | U = 1726.520 | 0.125 |
| RQLQ score | 83.933 ± 10.076 | 88.801 ± 8.872 | t = −1.405 | 0.171 |
| VAS scoreb | 7.036 ± 1.839 | 6.648 ± 1.379 | U = 1739.500 | 0.136 |
| TCM syndrome typea (number of patients) | x 2=1.030 | 0.794 | ||
| Insufficiency of the Spleen-qia | 25 | 23 | – | – |
| Insufficiency of the Lung-qia | 23 | 26 | – | – |
| Insufficiency of the Kidney-yanga | 9 | 6 | – | – |
| Retention of the Pathogenic Heat of the Lunga | 7 | 9 | – | – |
RQLQ Rhinitis Quality of Life Questionnaire, VAS Visual Analogue Scale
For each variable except gender and TCM syndrome type, the values are expressed as the means ± SD
aChi-square test
bWilcoxon rank-sum test for the non-normally distributed data
The categories without aor bwere analyzed with t test